CI Investments’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
CI Investments's CRL Position: Q3 2026 in Review
CI Investments increased its Charles River Laboratories (CRL) stake by 3.5% in Q3 2026, buying an estimated $10.8K and bringing the position to 1,229 shares worth $363K. The position accounts for ﹤0.01% of the portfolio, ranked #671.
CI Investments first reported a position in CRL in Q3 2021 and has held it in 19 quarters since. The position peaked at $62.6M in Q2 2023. 635 funds tracked by Wall St. Rank hold CRL as of Q3 2026.
- CI Investments held 1,229 shares of Charles River Laboratories worth $363K as of Q3 2026.
- CI Investments bought 41 Charles River Laboratories shares in Q3 2026, an estimated $10.8K.
- Charles River Laboratories made up ﹤0.01% of CI Investments's portfolio in Q3 2026, its #671 holding.
- CI Investments first reported a position in Charles River Laboratories in Q3 2021 and has held it in 19 quarters since.
- CI Investments's Charles River Laboratories position peaked at $62.6M in Q2 2023.
- 635 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.
Based on CI Investments's 13F filing for Q3 2026, filed 12 Nov 2026.